Imagen Network Enhances Content Discovery and Interaction with Grok AI Integration
CosmicUp Launches All-in-One Subscription Platform
Wellfield Technologies Inc. Provides Management Cease Trade Order Update
Sigma 300-600mm F4 DG OS | Sports Has Received EISA Ultra-Telephoto Zoom Lens 2025-2026
Federated Wireless Releases Position Paper Advocating 4 GHz Band as Path to 6G Leadership
MBX 2109 was observed to be generally well-tolerated MBX 2109 increased albumin adjusted serum calcium…
MBX 2109 was observed to be generally well-tolerated MBX 2109 increased albumin adjusted serum calcium…
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society…
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society…
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October…
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October…
Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using…
Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using…
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
-Researchers concluded that in the clinical study the HAV was a safe, resilient, and effective…
-Researchers concluded that in the clinical study the HAV was a safe, resilient, and effective…
Biotech industry veteran strengthens leadership team with decades of experience LEXINGTON, Mass., Sept. 11, 2023…
Biotech industry veteran strengthens leadership team with decades of experience LEXINGTON, Mass., Sept. 11, 2023…
Demonstrating potential safety and efficacy of WEE1 inhibitor, ATRN-1051, in the treatment of ovarian cancer…
Demonstrating potential safety and efficacy of WEE1 inhibitor, ATRN-1051, in the treatment of ovarian cancer…
Seattle, Sept. 11, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
Seattle, Sept. 11, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
The Company intends to increase its existing focus on inflammatory and autoimmune indications. The Company,…
The Company intends to increase its existing focus on inflammatory and autoimmune indications. The Company,…